These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8995035)

  • 1. Does renal osteodystrophy develop and/or progress during the course of rhGH treatment?
    Watkins SL
    Br J Clin Pract Suppl; 1996 Aug; 85():59-60. PubMed ID: 8995035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment?
    Watkins SL
    Pediatr Nephrol; 1996 Jun; 10(3):351-4. PubMed ID: 8792404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone disease in patients receiving growth hormone.
    Watkins SL
    Kidney Int Suppl; 1996 Jan; 53():S126-7. PubMed ID: 8771006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of one year therapy with recombinant human growth hormone (rhGH) on growth velocity, calcium-phosphorus metabolism, bone mineral density and changes in body composition in children with growth hormone deficiency (GHD)].
    Zak T; Basiak A; Zubkiewicz-Kucharska A; Noczyńska A
    Pediatr Endocrinol Diabetes Metab; 2010; 16(1):39-43. PubMed ID: 20529605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of renal osteodystrophy in peritoneal dialysis.
    Weinreich T
    Kidney Int; 1998 Dec; 54(6):2226-33. PubMed ID: 9853289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow immunoscintigraphy (BMIS): a new and important tool for the assessment of marrow fibrosis in renal osteodystrophy?
    Kim CD; Kim SH; Kim YL; Cho DK; Lee JT
    Adv Perit Dial; 1998; 14():183-7. PubMed ID: 10649720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Tönshoff B; Cronin MJ; Reichert M; Haffner D; Wingen AM; Blum WF; Mehls O
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1007-13. PubMed ID: 9100565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unresponsiveness of bone to PTH in aluminum-related renal osteodystrophy.
    Kawaguchi Y; Oda Y; Imamura N; Shigematu T; Kimura Y; Aizawa S; Fujimaki H; Shoji R; Tsukui I; Ogura Y
    Kidney Int Suppl; 1986 Feb; 18():S49-52. PubMed ID: 3457996
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the impact of recombinant human growth hormone (rhGH) on the plasma lipid profile beneficial or harmful?
    Querfeld U
    Br J Clin Pract Suppl; 1996 Aug; 85():54-5. PubMed ID: 8995033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Growth and renal function].
    Antoniazzi F; Mengarda F; Lauriola S; Serra A; Zamboni G; Tatò L
    Pediatr Med Chir; 1997; 19(5):341-7. PubMed ID: 9493225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding and managing hyperphosphatemia in patients with chronic renal disease.
    Malluche HH; Monier-Faugere MC
    Clin Nephrol; 1999 Nov; 52(5):267-77. PubMed ID: 10584989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of growth hormone treatment on bone metabolism in dialysis patients.
    Sieniawska M; Pañczyk-Tomaszewska M; Ziólkowska H
    Br J Clin Pract Suppl; 1996 Aug; 85():61-3. PubMed ID: 8995036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin A status of patients with chronic renal failure in relation to renal osteodystrophy].
    Stein G; Abendroth K; Kokot F; Keil E; Schöne S; Wessel G; Fünfstück R; Sperschneider H
    Z Urol Nephrol; 1985 Mar; 78(3):159-65. PubMed ID: 4002896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term experience of alfacalcidol in renal osteodystrophy.
    Sharman VL; Brownjohn AM; Goodwin FJ; Hately W; Manning RM; O'Riordan JH; Papapoulos SE; Marsh FP
    Q J Med; 1982; 51(203):271-8. PubMed ID: 7146311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.
    Janssen YJ; Hamdy NA; Frölich M; Roelfsema F
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2143-8. PubMed ID: 9626153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.
    Goodman WG; Duarte ME
    Miner Electrolyte Metab; 1991; 17(4):221-32. PubMed ID: 1813784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of PTH, 1,25(OH)2D3 and biochemistry in renal osteodystrophy].
    Jia JK; Lou DX; Zhu P
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):33-6. PubMed ID: 8045186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.